VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2021

Aug 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2021-08-02

Reporting Person: SACHS BRUCE I (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-02	Common Stock	P	15000	$197.91	Acquired	41210	Direct

Footnotes

F1: Open market sales reported on this line occurred at a weighted average price of $197.91 (range $197.45 to $198.12).

F2: Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.